Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 4, 2008, Pages 1048-1056

  Onder, Ali Mirza ^a   Chandar, Jayanthi ^b   Billings, A A ^a   Simon, Nancy ^c   Diaz, Rosa ^b   Francoeur, Denise ^b   Abitbol, Carolyn ^b   Zilleruelo, Gaston ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ARTICLE; BACTEREMIA; CHILD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; DRUG ADMINISTRATION; EQUIPMENT; EQUIPMENT DESIGN; FEMALE; HUMAN; INDWELLING CATHETER; INSTRUMENTATION; MALE; MICROBIOLOGY; RECURRENT DISEASE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERS, INDWELLING; CHILD; DRUG ADMINISTRATION SCHEDULE; EQUIPMENT CONTAMINATION; EQUIPMENT DESIGN; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RECURRENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 49149116408     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04931107     Document Type: Article

References (32)

1. Passerini L, Lam K, Costerton JW, King EG: Biofilms on indwelling vascular catheters. Crit Care Med 20: 665-673, 1992
2. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaisse E, Bodey GP: Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168: 400-407, 1993
3. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ: Antibiotic-lock technique: A new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J Parenter Enteral Nutr 12: 185-189, 1988
4. Bailey E, Berry N, Cheesbrough JS: Antimicrobial lock therapy for catheter-related bacteremia among patients on maintenance hemodialysis. J Antimicrob Chemother 50: 615-617, 2002
5. Capdevilla JA, Segarra A, Planes AM, Ramirez-Arellano M, Pahissa A, Piera L, Martinez-Vazquez JM: Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 8: 231-234, 1993
6. Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, Allon M: Management of hemodialysis catheter-related bacteremia with an adjunctive lock solution. Kidney Int 61: 1136-1142, 2002
7. Poole CV, Carlton D, Bimbo L, Allon M: Treatment of catheter-related bacteremia with an antibiotic lock protocol: Effect of bacterial pathogen. Nephrol Dial Transplant 19: 1237-1244, 2004
8. Rijnders BJ, Wijngaerden EV, Vandecasteele SJ, Stas M, Peetermans WE: Treatment of long-term intravascular catheter-related bacteremia with antibiotic lock: Randomized, placebo-controlled trial. J Antimicrob Chemother 55: 90-94, 2005
9. Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, Pigrau C, Pahissa A: Antibiotic-lock therapy for long-term intravascular catheter-related bacteremia: Results of an open, non-comparative study. J Antimicrob Chemother 57: 1172-1180, 2006
10. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA: Healthcare Infection Control Practices Advisory Committee: Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 30: 476-489, 2002
11. Vascular Access Work Group: Clinical practice guidelines for vascular access. Am J Kidney Dis 48[Suppl 1]: S248-S273, 2006
12. Besarab A, Adams M, Amatucci S, Bowe D, Deane J, Ketchen K, Reynolds K, Tello A: Unraveling the realities of vascular access: The Network 11 experience. Adv Ren Replace Ther 7[Suppl 1]: S65-S70, 2000
13. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ: Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 61: 305-316, 2002
14. Centers for Medicare & Medicaid Services: 2005 Annual Report, End-Stage Renal Disease Clinical Performance Measures Project, Baltimore, Department of Health and Human Services, Centers for Medicare & Medicaid Services, Center for Beneficiary Choices, 2005
15. Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL: Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): Performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis 44[Suppl 3]: S22-S26, 2004
16. Lumsden AB, MacDonald MJ, Allen RC, Dodson TF: Hemodialysis access in the pediatric patient population. Am J Surg 168: 197-201, 1994
17. Ramage IJ, Bailie A, Tyerman KS, McColl JH, Pollard SG, Fitzpatrick MM: Vascular access survival in children and young adults receiving long-term hemodialysis. Am J Kidney Dis 45: 708-715, 2005
18. Bourquelot P, Raynaud F, Pirozzi N: Microsurgery in children for creation of arteriovenous fistulas in renal and non-renal diseases. Ther Apher Dial 7: 498-503, 2003
19. Gradman WS, Lerner G, Mentser M, Rodriguez H, Kamil ES: Experience with autogenous arteriovenous access for hemodialysis in children and adolescents. Ann Vasc Surg 19: 609-612, 2005
20. Onder AM, Chandar J, Coakley S, Abitbol C, Montane B, Zilleruelo G: Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis. Pediatr Nephrol 21: 1452-1458, 2006
21. Haimi-Cohen Y, Husain N, Meenan J, Karayalcin G, Lehrer M, Rubin LG: Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: Simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents Chemother 45: 1565-1567, 2001
22. Anthony TU, Rubin LG: Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother 43: 2074-2076, 1999
23. Goldstein SL, Macierowski CT, Jabs K: Hemodialysis catheter survival and complications in children and adolescents. Pediatr Nephrol 11: 74-77, 1997
24. Sharma A, Zilleruelo G, Abitbol C, Montane B, Strauss J: Survival and complications of cuffed central venous catheters in children and young adults on chronic hemodialysis. Pediatr Nephrol 13: 245-248, 1999
25. Paglialonga F, Esposito S, Edefonti A, Principi N: Catheter-related infections in children treated with hemodialysis. Pediatr Nephrol 19: 1324-1333, 2004
26. Powe NR, Jaar B, Furth SL: Septicemia in dialysis patients: Incidence, risk factors and prognosis. Kidney Int 55: 1081-1090, 1999
27. Kovalik EC, Raymond JR, Albers FJ, Berkoben M, Butterfly DW, Montella B, Conlon PJ: A clustering of epidural abscesses in chronic hemodialysis patients: Risk of salvaging access catheters in cases of infection. J Am Soc Nephrol 7: 2264-2267, 1996
28. Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Depner TA, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ: HEMO Study Group: The spectrum of infection-related morbidity in hospitalized hemodialysis patients. Nephrol Dial Transplant 20: 1180-1186, 2005
29. Saad TF: Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 34: 1114-1124, 1999
30. Shroff GR, Herzog CA, Ma JZ, Collins AJ: Long-term survival of dialysis patients with bacterial endocarditis in the United States. Am J Kidney Dis 44: 1077-1082, 2004
31. Marr KA, Schwab SJ, Sexton D, Conlon P: Bacteremia in patients with central venous catheters used for hemodialysis: Lack of evidence of catheter salvage. Ann Intern Med 127: 275-280, 1997
32. Beathard GA: Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10: 1045-1049, 1999